Green PS, Mendez AJ, Jacob JS, Crowley JR, Growdon W, Hyman BT et al
The SELECT trial, results of which were published in the New England Journal of Medicine on 11 November 2023, included 17,604 patients who were overweight or had obesity and were aged over 45 years or older with pre-existing cardiovascular disease
He added that the new deal may reflect Novo Nordisk's efforts to reposition itself following underwhelming late-stage data on its other experimental obesity drug called CagriSema
But here is the thing most people miss: thirst is not listed as a direct side effect in the FDA prescribing information for Mounjaro or Zepbound
May 31 2011;123(21):2434-506
Each bottle contains 20mg total